Regulatory Overhaul Needed For Innovative Techs, Gottlieb Says

In a speech last week, former US FDA Commissioner Scott Gottlieb said establishing dynamic tools, including active registries and firm-based regulation, will be crucial to the FDA’s ability to regulate emerging technologies.